At the news
? NEUTRALIMPACT 2/10 6-K filed Jun 11, 2026 at 13:58 ET
Genmab A/S filed a 6-K reporting a routine grant of 15,894 restricted stock units and 15,494 warrants to employees. The grants are standard long-term incentive compensation with 3-year vesting, representing a minimal and immaterial dilution relative to the company's $15.7B market cap.
- Grant of 15,894 restricted stock units and 15,494 warrants to employees on June 11, 2026.
- RSU fair value of DKK 1,616.50 per unit (closing price on grant date); warrant fair value of DKK 534.23 per warrant (Black-Scholes).
- Both instruments vest three years from grant date; warrants expire at the seventh anniversary.
- The awards are cost-free to recipients; exercise price per warrant is DKK 1,616.50.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access